Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-11-14 Purchase | 2024-11-15 2:43 pm | Assertio Holdings Inc. | ASRT | O'Grady Brendan P. CEO | 11,706 | $0.85 | $9,950 | 11,706 (Direct) | View |
| 2021-03-04 Sale | 2021-03-08 4:09 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | O'Grady Brendan P. EVP, North America Commercial | 19,608 | $10.56 | $207,091 | 161,994 (Direct) | View |
| 2021-03-02 Sale | 2021-03-04 4:05 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | O'Grady Brendan P. EVP, North America Commercial | 15,548 | $10.85 | $168,631 | 15,571 (Direct) | View |
| 2021-03-01 Sale | 2021-03-02 4:07 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | O'Grady Brendan P. EVP, North America Commercial | 73,127 | $10.91 | $798,023 | 104,758 (Direct) | View |
| 2021-02-09 Sale | 2021-02-11 4:08 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | O'Grady Brendan P. EVP, North America Commercial | 20,694 | $12.69 | $262,700 | 94,267 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-05-31 Tax Withholding | 2025-06-03 6:00 pm | N/A N/A | Assertio Holdings Inc. | ASRT | O'Grady Brendan P. CEO | 49,416 | $0.6643 | 462,290 (Direct) | View |
| 2025-05-31 Exercise | 2025-06-03 6:00 pm | N/A 2027-05-31 | Assertio Holdings Inc. | ASRT | O'Grady Brendan P. CEO | 166,665 | $0 | 462,290 (Direct) | View |
| 2025-02-18 Option Award | 2025-02-20 6:00 pm | N/A 2028-02-18 | Assertio Holdings Inc. | ASRT | O'Grady Brendan P. CEO | 1,255,525 | $0 | 1,255,525 (Direct) | View |
| 2024-05-31 Option Award | 2024-06-04 6:01 pm | N/A 2027-05-31 | Assertio Holdings Inc. | ASRT | O'Grady Brendan P. CEO | 2,300,000 | $0 | 2,300,000 (Direct) | View |
| 2021-03-04 Exercise | 2021-03-08 4:09 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | O'Grady Brendan P. EVP, North America Commercial | 18,905 | $0 | 161,994 (Direct) | View |
| 2021-03-05 Option Award | 2021-03-08 4:09 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | O'Grady Brendan P. EVP, North America Commercial | 109,315 | $0 | 161,994 (Direct) | View |
| 2021-03-03 Exercise | 2021-03-04 4:05 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | O'Grady Brendan P. EVP, North America Commercial | 1,166 | $0 | 15,571 (Direct) | View |
| 2021-02-28 Exercise | 2021-03-02 4:07 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | O'Grady Brendan P. EVP, North America Commercial | 24,934 | $0 | 104,758 (Direct) | View |
| 2021-02-09 Exercise | 2021-02-11 4:08 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | O'Grady Brendan P. EVP, North America Commercial | 16,120 | $0 | 94,267 (Direct) | View |
| 2021-02-09 Option Award | 2021-02-11 4:08 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | O'Grady Brendan P. EVP, North America Commercial | 67,852 | $0 | 94,267 (Direct) | View |